Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2

被引:48
作者
Owczarek, CM
Hwang, SY
Holland, KA
Gulluyan, LM
Tavaria, M
Weaver, B
Reich, NC
Kola, I
Hertzog, PJ
机构
[1] MONASH UNIV, INST REPROD & DEV, MOL GENET & DEV GRP, CLAYTON, VIC 3168, AUSTRALIA
[2] SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA
关键词
D O I
10.1074/jbc.272.38.23865
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This report describes the cloning of cDNAs encoding transmembrane and soluble isoforms of a novel chain of the murine type I interferon (IFN) receptor and characterization of its capability to bind ligand and transduce signals, The transmembrane receptor (murine IFNAR 2c) has an extracellular domain of 215 amino acids and an intracellular domain of 250 amino acids, with 48% amino acid and 71% nucleotide identity with human IFNAR 2c, The cDNA for the soluble murine receptor (IFNAR 2a) encodes a 221-amino acid polypeptide identical to the first 210 amino acids of IFNAR 2c plus a novel 11 amino acids, Northern blot analyses show that murine IFNAR 2 is expressed as two transcripts of 4 kilobases encoding the transmembrane isoform and 1.5 kilobases encoding the more abundant soluble isoform, Studies using primary murine cells that lack IFNAR 1 show that IFNAR 2 is expressed, and cells bind type I IFN ligand, but do not transduce signals as detected by electrophoretic mobility shift assays of ISGF3 or GAF complexes binding to their cognate oligonucleotides, These cells show no effects on the ability of IFN gamma to activate these complexes, These studies demonstrate that the IFNAR 2 transmembrane (2c) and soluble (2a) isoforms are conserved between the human and mouse and that IFNAR 2c has intrinsic ligand binding activity, but no intrinsic signal transducing activity as measured in this study.
引用
收藏
页码:23865 / 23870
页数:6
相关论文
共 29 条
[11]   A NULL MUTATION IN THE GENE ENCODING A TYPE-I INTERFERON RECEPTOR COMPONENT ELIMINATES ANTIPROLIFERATIVE AND ANTIVIRAL RESPONSES TO INTERFERON-ALPHA AND INTERFERON-BETA AND ALTERS MACROPHAGE RESPONSES [J].
HWANG, SY ;
HERTZOG, PJ ;
HOLLAND, KA ;
SUMARSONO, SH ;
TYMMS, MJ ;
HAMILTON, JA ;
WHITTY, G ;
BERTONCELLO, I ;
KOLA, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11284-11288
[12]   Binding of interferon-alpha and -beta to a component of the human type I interferon receptor expressed in simian cells [J].
Hwang, SY ;
Holland, KA ;
Kola, I ;
Hertzog, PJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1996, 28 (08) :911-916
[13]   REQUIREMENT OF TYROSINE PHOSPHORYLATION FOR RAPID ACTIVATION OF A DNA-BINDING FACTOR BY IL-4 [J].
KOTANIDES, H ;
REICH, NC .
SCIENCE, 1993, 262 (5137) :1265-1267
[14]   Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene [J].
Kotanides, H ;
Reich, NC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25555-25561
[15]   INTRINSIC LIGAND-BINDING PROPERTIES OF THE HUMAN AND BOVINE ALPHA-INTERFERON RECEPTORS [J].
LIM, JK ;
XIONG, JW ;
CARRASCO, N ;
LANGER, JA .
FEBS LETTERS, 1994, 350 (2-3) :281-286
[16]  
LOVELAND BE, 1992, BIOCHEM INT, V27, P501
[17]  
LUTFALLA G, 1995, EMBO J, V14, P101
[18]   FUNCTIONAL-ROLE OF TYPE-I AND TYPE-II INTERFERONS IN ANTIVIRAL DEFENSE [J].
MULLER, U ;
STEINHOFF, U ;
REIS, LFL ;
HEMMI, S ;
PAVLOVIC, J ;
ZINKERNAGEL, RM ;
AGUET, M .
SCIENCE, 1994, 264 (5167) :1918-1921
[19]   AN ALU CASSETTE IN THE CYTOPLASMIC DOMAIN OF AN INTERFERON RECEPTOR SUBUNIT [J].
MULLERSMAN, JE ;
PFEFFER, LM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (09) :815-817
[20]   THE HUMAN INTERFERON-ALPHA/BETA RECEPTOR - CHARACTERIZATION AND MOLECULAR-CLONING [J].
NOVICK, D ;
COHEN, B ;
RUBINSTEIN, M .
CELL, 1994, 77 (03) :391-400